1773P Mainstreamed genetic testing for French breast and ovarian cancer patients and its utility during the COVID-19 pandemic

por Benusiglio, P.R., Korenbaum, C., Ezenfis, J., Geoffron, S., Paul, C., Richard, S., Byrde, V., Guillerm, E., Basset, N., Lotz, J-P., Chabbert-Buffet, N., Gligorov, J., Coulet, F.
Publicado 2020

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer

por Benusiglio, P R, Pharoah, P D, Smith, P L, Lesueur, F, Conroy, D, Luben, R N, Dew, G, Jordan, C, Dunning, A, Easton, D F, Ponder, B A J
Publicado 2006

Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019

por Suerink, M., Wimmer, K., Brugieres, L., Colas, C., Gallon, R., Ripperger, T., Benusiglio, P. R., Bleiker, E. M. A., Ghorbanoghli, Z., Goldberg, Y., Hardwick, J. C. H., Kloor, M., le Mentec, M., Muleris, M., Pineda, M., Ruiz-Ponte, C., Vasen, H. F. A.
Publicado 2020